Alfredo Nicosia

USPTO Granted Patents = 26 (Patent Applications = 20)

CIPO Patents = 6 (Patent Applications = 12)

EPO Patents = 12 (Patent Applications = 19)

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 115(Granted Patents)

Location History:

Naples, IT (2021 - 2023)
Rome, IT (1999 - 2024)

Company Filing History:

12 out of 531

Glaxosmithkline Biologicals Sa

patents

4 out of 47

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

National Institutes of Health, a Component of the US Dept. of Health & Human Services

Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.p.a.

Sabin Vaccine Institute

patent

9. 1 out of 1

Ceingebiotecnologie Avanzate Franco Salvatore Scarl

patent

10. 1 out of 77

University of Copenhagen

patents

11. 1 out of 2,405

Merck Sharp + Dohme Corp.

patents

12. 1 out of 1

Istituto Di Recerche Di Biologia Moleculare P. Angeletti S.p.a.

patent

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12152074 - Antagonistic PD-1, PD-L1 and LAG-3 binding proteins (2024-11-26),

2. 11913013 - Chimpanzee adenoviral vector-based filovirus vaccines (2024-02-27),

3. 11701422 - Expression systems (2023-07-18),

4. 11643666 - Eukaryotic cell line (2023-05-09),

5. 11578109 - Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers (2023-02-14),

6. 11498956 - Fusion peptides with antigens linked to short fragments of invariant chain(CD74) (2022-11-15),

7. 11278614 - Poxviral vaccines (2022-03-22),

8. 11254711 - Adenovirus polynucleotides and polypeptides (2022-02-22),

9. 11254710 - Adenovirus polynucleotides and polypeptides (2022-02-22),

10. 11214599 - Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof (2022-01-04),

11. 11098324 - Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof (2021-08-24),

12. 10588961 - Poxviral vaccines (2020-03-17),

13. 10584355 - Chimpanzee adenoviral vector-based filovirus vaccines (2020-03-10),

14. 10576143 - Poxviral vaccines (2020-03-03),

15. 10544192 - Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof (2020-01-28),

Title: The Innovative Journey of Alfredo Nicosia

Introduction: Alfredo Nicosia, a visionary inventor hailing from Rome, Italy, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Alfredo Nicosia's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a sustainable energy solution for urban environments, and a medical device aimed at improving patient care.

Career Highlights: With a career spanning over two decades, Alfredo Nicosia has established himself as a leading figure in the world of innovation. He has worked with renowned tech companies, research institutions, and universities to bring his ideas to life.

Collaborations: Throughout his career, Alfredo Nicosia has collaborated with top engineers, designers, and scientists to develop innovative solutions to complex problems. His ability to work across disciplines has led to the creation of groundbreaking technologies.

Conclusion: Alfredo Nicosia's passion for innovation and his relentless pursuit of excellence have cemented his reputation as a trailblazer in the world of technology. His inventions continue to inspire and shape the future of various industries.

This text is generated by artificial intelligence and may not be accurate.